Carrara, S.C.; Bogen, J.P.; Fiebig, D.; Grzeschik, J.; Hock, B.; Kolmar, H.
Targeted Phagocytosis Induction for Cancer Immunotherapy via Bispecific MerTK-Engaging Antibodies. Int. J. Mol. Sci. 2022, 23, 15673.
https://doi.org/10.3390/ijms232415673
AMA Style
Carrara SC, Bogen JP, Fiebig D, Grzeschik J, Hock B, Kolmar H.
Targeted Phagocytosis Induction for Cancer Immunotherapy via Bispecific MerTK-Engaging Antibodies. International Journal of Molecular Sciences. 2022; 23(24):15673.
https://doi.org/10.3390/ijms232415673
Chicago/Turabian Style
Carrara, Stefania C., Jan P. Bogen, David Fiebig, Julius Grzeschik, Björn Hock, and Harald Kolmar.
2022. "Targeted Phagocytosis Induction for Cancer Immunotherapy via Bispecific MerTK-Engaging Antibodies" International Journal of Molecular Sciences 23, no. 24: 15673.
https://doi.org/10.3390/ijms232415673
APA Style
Carrara, S. C., Bogen, J. P., Fiebig, D., Grzeschik, J., Hock, B., & Kolmar, H.
(2022). Targeted Phagocytosis Induction for Cancer Immunotherapy via Bispecific MerTK-Engaging Antibodies. International Journal of Molecular Sciences, 23(24), 15673.
https://doi.org/10.3390/ijms232415673